Morocco
· Delayed Price · Currency is MAD Med Paper Statistics
Total Valuation
Med Paper has a market cap or net worth of MAD 98.02 million. The enterprise value is 306.09 million.
| Market Cap | 98.02M |
| Enterprise Value | 306.09M |
Important Dates
The next estimated earnings date is Friday, December 27, 2024.
| Earnings Date | Dec 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Med Paper has 4.78 million shares outstanding.
| Shares Outstanding | 4.78M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 17.04.
| PE Ratio | 17.04 |
| Forward PE | n/a |
| PS Ratio | 0.91 |
| PB Ratio | 3.71 |
| P/FCF Ratio | 11.88 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.79, with an EV/FCF ratio of 37.10.
| EV / Earnings | 53.22 |
| EV / Sales | 2.84 |
| EV / EBITDA | 18.79 |
| EV / EBIT | 28.13 |
| EV / FCF | 37.10 |
Financial Position
The company has a current ratio of 0.88, with a Debt / Equity ratio of 7.88.
| Current Ratio | 0.88 |
| Quick Ratio | 0.60 |
| Debt / Equity | 7.88 |
| Debt / EBITDA | 12.79 |
| Debt / FCF | 25.25 |
| Interest Coverage | 2.32 |
Financial Efficiency
Return on equity (ROE) is 24.40% and return on invested capital (ROIC) is 3.04%.
| Return on Equity (ROE) | 24.40% |
| Return on Assets (ROA) | 2.04% |
| Return on Capital (ROIC) | 3.04% |
| Revenue Per Employee | 314,471 |
| Profits Per Employee | 16,766 |
| Employee Count | 343 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 1.12 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.30% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -9.30% |
| 50-Day Moving Average | 21.60 |
| 200-Day Moving Average | 19.88 |
| Relative Strength Index (RSI) | 46.05 |
| Average Volume (20 Days) | 4,155 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Med Paper had revenue of MAD 107.86 million and earned 5.75 million in profits. Earnings per share was 1.20.
| Revenue | 107.86M |
| Gross Profit | 50.87M |
| Operating Income | 10.87M |
| Pretax Income | 6.02M |
| Net Income | 5.75M |
| EBITDA | 16.28M |
| EBIT | 10.87M |
| Earnings Per Share (EPS) | 1.20 |
Balance Sheet
The company has 238,548 in cash and 208.30 million in debt, giving a net cash position of -208.07 million or -43.49 per share.
| Cash & Cash Equivalents | 238,548 |
| Total Debt | 208.30M |
| Net Cash | -208.07M |
| Net Cash Per Share | -43.49 |
| Equity (Book Value) | 26.45M |
| Book Value Per Share | 5.53 |
| Working Capital | -22.93M |
Cash Flow
In the last 12 months, operating cash flow was 11.55 million and capital expenditures -3.30 million, giving a free cash flow of 8.25 million.
| Operating Cash Flow | 11.55M |
| Capital Expenditures | -3.30M |
| Free Cash Flow | 8.25M |
| FCF Per Share | 1.72 |
Margins
Gross margin is 47.16%, with operating and profit margins of 10.08% and 5.33%.
| Gross Margin | 47.16% |
| Operating Margin | 10.08% |
| Pretax Margin | 5.58% |
| Profit Margin | 5.33% |
| EBITDA Margin | 15.10% |
| EBIT Margin | 10.08% |
| FCF Margin | 7.65% |
Dividends & Yields
Med Paper does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 5.87% |
| FCF Yield | 8.42% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Med Paper has an Altman Z-Score of 0.47. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.47 |
| Piotroski F-Score | n/a |